|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.196 RON | -1.01% |
|
-1.51% | -2.00% |
| Apr. 25 | S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Ropharma provided earnings guidance for the full year 2014. The company targets a net profit of RON 9.0 million in 2014, up from RON 7.2 million last year. Operating revenue is seen at RON 433 million versus RON 414 million in 2013.
The shareholders also approved an investment budget worth RON 7.2 million for this year.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.00% | 21.98M | |
| -21.31% | 3.22B | |
| -11.23% | 2.98B | |
| -28.80% | 2.83B | |
| +9.43% | 2.71B | |
| -27.98% | 1.74B | |
| +8.32% | 1.35B | |
| -33.48% | 804M | |
| -52.23% | 542M | |
| +2.47% | 450M |
S.C. ROPHARMA S.A. 
